Back to Results
First PageMeta Content
Cardiac dysrhythmia / Alcohols / Janssen Pharmaceutica / Organochlorides / QT interval / Torsades de pointes / Long QT syndrome / Pimozide / Moxifloxacin / Chemistry / Organic chemistry / Organofluorides


6-01-b EMA[removed]Final PhVWP report to CMDh- Escitalopram
Add to Reading List

Document Date: 2012-01-30 08:42:15

Open Document

File Size: 33,71 KB

Share Result on Facebook

Event

Product Issues / Product Recall / /

IndustryTerm

medicinal products / /

MedicalCondition

stable cardiac disease / significant bradycardia / congestive heart failure/bradyarrhythmias / cardiac arrhythmia / vomiting / torsade de pointes / heart attack / Torsades de Pointes / Cardiac disorders / cardiac disease / fainting / congenital long QT syndrome / dizziness / uncompensated heart failure / cardiac diseases / ventricular arrhythmia / acute myocardial infarction / /

Product

haloperidol / erythromycin / cimetidine / Escitalopram / /

Technology

pharmacokinetics / /

SocialTag